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Why Bother?
RAND Europe
• Independent not-for-profit public policy research institute
“help improve policy and decision making through research and analysis”
• Part of the RAND Corporation
• Strongly held values of quality and objectivity
•Openly disseminate our work
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Policy-focused programmes
Method-focused groups
OPENNESS & ACCESS: 'JUST' A SERVICE OR A HUMAN RIGHT?The internet's open protocols allow useful innovations to emerge, e.g., instant messaging, without developers needing anyone's permission. However, this openness is under threat. Commercial service providers are demanding payment for access, while governments seek to filter out 'undesirable' information for political reasons. There is also a risk of fragmentation as more countries get online, generating more languages and characters to be supported. And most of the world's population is still excluded: 5.3 billion potential consumers and entrepreneurs are waiting to enter the virtual space, but domain capacity is fast running out.   Implications for government:< Embrace global diversity of internet and accept loss of some control <Support and lead in the use of open standards and interoperability to ensure open, affordable access <Introduce standardised formats for non-Latin scripts<Lead in introducing IPv6* to increase address space
BACKGROUNDThe internet has developed at extraordinary speed from an information-sharing system for scientists to a worldwide driver of economic growth. Knowledge travels faster, consumers can interact across borders and create their own media content, and new markets and entrepreneurs emerge daily.But the uniquely global and open nature of the internet also creates challenges for governments in areas such as privacy, security, intellectual property rights (IPR) and the accountability for behaviour online. In Autumn 2007, the Dutch Ministry of Economic Affairs commissioned a study by RAND Europe into the changes caused by the emerging internet economy and the implications for policy making, in preparation for the 2008 OECD Ministerial Conference. 
RESEARCH APPROACHRAND Europe adopted a three-stage methodology:<A literature review to define the most pressing social and economic policy issues<A survey of 40 global experts to test and prioritise the list<Four half-day seminars with expert participants to identify trends and possible options 
What is the role of government in a borderless internet world?RAND Europe assesses the implications for policy makers
IMPACT< Influencing international policy. The report directly informed the Dutch government's policy line in the 2008 OECD Ministerial Conference, and was accepted as a reference document for participants. < Informing domestic policy. The research provides a framework for future policy in areas such as internet governance, IPR, self-regulation and information security.<Wider public debate. The Ministry is launching a public information initiative to explain the challenges and opportunities of the internet, presenting RAND Europe’s research findings in a simple, visual way. * Internet Protocol version 6 (for more information, see www.ipv6.org)
THE WAY FORWARD?'LIGHT TOUCH' LOCAL AND GLOBAL GOVERNANCEOpenness and transparency are essential to the internet economy, allowing creative entrepreneurial individuals to flourish. National governments must embrace these traits and accept that they cannot single-handedly control the behaviour of 'their' citizens in this new borderless world. At a local level, governments should work collaboratively with service providers and user communities to  encourage participation and effective self-regulation. This may be backed up by 'traditional' regulatory measures, if needed. At the global level, the internet needs a pan-national governance structure that is inclusive, agile and 'light-touch'. This is a formidable challenge, as new constituencies, technologies, applications and threats emerge. The Internet Governance Forum 2006-2010 and the Working Group on Internet Governance present hopeful first initiatives, which need formal endorsement and further development. General principles of good governance can provide guidance, such as transparency, proportionality, accountability, public awareness and participation.
PEOPLE & PARTICIPATION: HOW QUICKLY CAN WE CHANGE THE WORLD?The internet empowers individuals and businesses by creating new forms of participation and wealth-creation. Anyone connected to the internet can communicate with, deliver services to and publish content for the rest of the world. New forms of civic participation are influencing public policy. Innovative business models are emerging built on input from consumers, users and experts.However, skills and access are unevenly distributed. Government and business need to ensure that all citizens can benefit. In addition to traditional IPR, new tangible and intangible rights (such as spectrum) are shaping markets and opportunities. The challenge is to ensure that IPR policies encourage participation, rather than concentrate market power. Implications for government:<Redefine the role of government as an enabler for self-organisation to stimulate social innovation, collaboration and best practice sharing <Take a user-oriented approach to governance <Use new means to prevent or bridge divides, e.g., locations, generations, education<Support innovation through intelligent IPR policies 
os or Control?C ha
TRUST:  CAN GOVERNMENTS PROTECT US FROM ONLINE RISK?The internet is the most efficient marketplace ever created, increasing competition and allowing more information to be collected and exchanged.  While these features drive innovation and economic growth, they also create security and privacy risks. Online crime and fraud are booming. Privacy concerns are also rising. More data can be collected automatically, such as credit card details and buying habits. Roaming devices and location sensors can show who is nearby and what they are doing. These developments undermine user trust and uptake, but measures to restore confidence typically increase costs and may reduce access and user-friendliness. Rather than strive for full security, users need to be aware of risks, and the options for risk-management and redress. Implications for government:<Help citizens and businesses understand that full security is unachievable and adopt appropriate risk-management and reduction strategies < Support tools and protocols that enable secure transactions, including IPv6*; help enforce certification (including self-certification) of services <Stay alert to new threats such as semantic attacks, and possible public policy needs
Can social science pass
Can a health research evaluation model be applied to social science?RAND Europe's work with the Payback Framework
 a medical?
BACKGROUNDOrganisations that fund research are under increasing pressure to justify their expenditure and demonstrate its wider value to society. In 2006, the ESRC – the UK's largest funder of social science research – gave over £90 million in grants. However, there are few mechanisms in place to assess the impact of social science research. Most work on research measurement to date has been in the biomedical and health sciences. RAND Europe was asked to evaluate the Future of Work (FoW) programme, a £4 million ESRC-funded programme to investigate the future of paid and unpaid work. The project was intended to have both academic and policy impacts, making it an interesting subject for impact analysis. 
IMPACTFlexible dynamic model. The Payback Framework can be effectively applied to social science, giving a broader view than single focus measures such as bibliometrics. It is also flexible, allowing researchers to assess the interplay between activity and impacts. Wide range of impacts. Multiple inputs and incremental policy creep make it difficult to attribute social policy change to a given input. While these difficulties remain, the framework is particularly suited to tracking the practical impact of research outside the academic field. Potential targeting tool. Identifying the characteristics of research projects that successfully translate their research into impact on policy would allow the ESRC to target funding at that type of project, if they wished.Validation of model by health research policymakers. There is a continued demand for the use of the payback approach in the area of health research. RAND Europe is working with the Irish Health Research Board to identify economic returns on health. Similarly, RAND Europe is working internationally with funders of cardiovascular disease research to investigate outcomes.
MOST EFFECTS OCCUR EARLY ONThe FoW analysis suggests that many impacts occur sooner than expected, often within 3-5 years of a grant ending.  One may not be able to generalise this finding, as FoW was a two-phase programme and may have funded the best or most impact-oriented researchers. If confirmed, however, it is an important finding, suggesting that evaluators need to start tracking impact much earlier, particularly for 'hot' topics.
NETWORKS ARE KEY TO INFLUENCING POLICY The FoW programme had a significant impact on knowledge and policy development. By using case studies to examine the process of impact in detail, we identified some key factors that helped FoW to succeed:Direct access to networks. The FoW programme director had many contacts in policy circles, which gave researchers access to policy makers in the Department for Trade & Industry, the Cabinet Office and the Low Pay Unit. These networks greatly facilitated the dissemination of findings. Targeted communication. The programme employed a Media Fellow, a former journalist at the Financial Times, who produced communications aimed at policy makers, helping them to quickly access and apply the research. Good timing. The FoW programme was launched in 1997, shortly after the election of a new Labour government seeking social science evidence to support proposed changes in policy. 
RESEARCH APPROACHOur starting point was the Payback Framework, a multi-dimensional tool developed by the Health Economics Research Group (HERG) at Brunel University.  RAND Europe has successfully applied this tool to assess the wider impact of health research, e.g. for the Arthritis Research Campaign. We set out to investigate whether this model could be adapted for use in evaluating social science research. The Payback Framework is built around a logic model of the biomedical  research process (see right), which we found to be equally applicable to social science. Impact is then assessed in a number of payback categories. 
Topic/IssueIdentification
Projectspecificationandselection Inputs toResearch Adoption
SecondaryOutputs
Direct Impact fromProcesses andPrimary Outputs toAdoption
Dissemination
Stock or Reservoir of Knowledge
DirectFeedbackPaths
ResearchProcess PrimaryOutputs FinalOutcomes
Payback Framework Logic Model
PAYBACK CATEGORIES ADAPTED WELL TO SOCIAL SCIENCE ENVIRONMENT We found that the payback categories could be credibly and usefully adapted to social science research, based on literature review and interviews. The model needed to accommodate the diversity of inputs to social policy making, and of possible or desirable outcomes. 
FROM...Health
Knowledge production
Research targeting and capacity building
Informing policy and product development
Health and health sector benefits
Broader economic benefits
Social Science...TO
Knowledge
Impacts on practice
Impacts on future research
In health, the benefits to individual health or the health sector are obvious and can be separated from the benefits to the economy. In social science research, benefits to one sector may be at the expense of another, and often include broader social benefits, e.g. better working conditions.
Impacts on policy
Wider social and economic benefits
Both science and social science build on research in similar ways, creating new research questions, methods and/or data sets, and new career opportunities. 
In health, policies and products are seen as similar outcomes that lead to better decisions or health products. In social science, policy decisions are typically taken at an organisational level, while informing practice implies changes in individual behaviour. These may or may not reflect policy, e.g. shopkeeper practices may not be in line with government policy on small business reporting.
Basis for changeKnowledge in health sciences is typically published in academic journals, so it can be bibliometrically identified. In social science, outputs are often widely disseminated, in books, book chapters, working papers and other media.
Most policy impactsoccur soon afterthe grant ends
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•Thoroughly pointless
•Trivial
•Tiresome
•Tick boxing
•Tedious
•Totally ridiculous
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How much 
spillover?
How much 
health gain?
To arrive at a number for the return on 
investment, we made three key estimates
How much was 
spent 
on research?
How long 
does it take?
From 1975-1992, £2 billion in public and 
charitable funding went to UK cardiovascular 
research
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Estimating the monetised health gains from 
specific interventions for CVD diseases
• Identify research based interventions that contributed most to 
cardiovascular health
• Estimate Quality Adjusted Life Year (QALY) gains per intervention
• Estimate number of users
• Adjusted for compliance and polytreatment
•Mulitply up to get total QALYs gained - 3.7 million
•Multiply by value of QALY - £25,000 - £92 billion
• Substract costs of delivering care - £75 billion
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To arrive at a number for the return on 
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+ Period between funding and publication and period between 
recommendation and use
Mean age is 12.5 years 
How was it used?
39%
• “few studies that have made a genuine attempt to objectively 
assess the economic returns of research” – Nature
What impact did it have?
•Cited in 
parliamentary 
debates
•News media
Unanswered questions
• Is that really the time lag?
• What about other diseases?
• Is the spillover estimate right?
• How does domestic research affect other countries?
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Breaking impact into atoms
• Knowledge production
• Research targeting and capacity building
• Informing policy and product development
• Health and health sector benefit
• Broader economic benefit
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• Research careers
• Research tools
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Breaking impact into atoms
• Research targeting and capacity building
• Interactions with academia
• Have you had initial discussions about collaboration of 
informal knowledge exchange?
• Did these discussions lead to co-applications for funding?
• Were these successful?
• And/or, did these discussions lead to 
co-publications?
• And/or, did the discussions lead to Material Transfer 
Agreements (MTAs)?
• And/or, did these discussions lead to sharing of reagents 
without MTAs?
No
Yes
Yes
Breaking impact into atoms
• Research targeting and capacity building
• Interactions with academia
• Have you had initial discussions about collaboration of 
informal knowledge exchange?
• Did these discussions lead to co-applications for funding?
• Were these successful?
• And/or, did these discussions lead to 
co-publications?
• And/or, did the discussions lead to Material Transfer 
Agreements (MTAs)?
• And/or, did these discussions lead to sharing of reagents 
without MTAs?
Yes
Yes
No
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Grant 3
Grant 4
Grant 5

How long it takes
How the data is being used
• Providing a map of IP generating activities for follow up
• Looking at time lags to allow comparison with other 
funders
• Providing input to selection panels
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Breadth and depth
Project Retrosight
• 29 Case studies of research 
grants awarded in the early 
1990s
• Across UK, Canada and 
Australia countries
• Analysed to look at the nature 
of impact and factors that 
correlate with impact
• International Consortium
Why cardiovascular research?
• Important disease 
area
• ‘Lab rat of Science of 
Science’
• Availability of funding
Australian Canda UK
Mortality
Morbidity
Total Annual 
Costs to 
National 
Economy
Annual 
Research 
Spending
38% 30% 35%
18% 5% 13%
$10.5 
billion
$15.0 
billion
$53.3 
billion
$120.9 
million
$66.6 
million
$191.5 
million
All figures in US dollars
Wider 
Impacts
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Impacts
Basic 
Research
Clinical 
Research
How do we go about it?
Select 
Case 
Studies
Select 
case 
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Build 
case 
studies Theme case 
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Rate case 
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Identify 
factors 
associated 
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Impact
How did we select case studies?
Random Survey
High 
impact
Low 
impact
Clinical
Basic
List of 
1347 
grants
High 
impact
Low 
impact
Clinical
Basic
How did we build the case 
studies?
• Read papers
• Did bibliometrics
• Read archives
• Interviewed PIs
How do we structure the case 
studies?

Variety of impacts
List of impacts
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Impact Scores
Academic Wider
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Collaboration
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-ve Results
Clinical Motivations
Yes
No
No
Yes
Story
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo 
inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, 
sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, 
consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad 
minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum 
iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?
Payback Scores
KP RTCB IPPD HHSB BEB
8 4 2 2 0
There Is Substantial Diversity Across the 
Five Payback Categories
Knowledge production impacts
• Project looking at 
genetic determinants 
of increased growth 
of vascular smooth 
muscle in 
spontaneously 
hypertensive rats 
• Produced 16 articles 
that were cited 849 
times
Health impacts
• Project analyzing the 
automated defibrillators 
in Scotland’s 
ambulances
• Widely cited in policies 
and made an 
important contribution 
to the increased 
survival rate following 
out-of-hospital cardiac 
arrest
Economic impact
• Project that developed 
animal models of 
myocardial dysfunction
• Led to commercial 
transgenic facility
• Now a multimillion-
dollar business that 
exports 80% of its 
services
How did we rate the case studies?
• International panel of 9 
experts
• 0-9 scale
• Rated each case study, 
on each payback 
category
Spread of impacts
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Economic impacts come from 
a minority of the case studies
0
1
2
3
4
5
6
7
8
9
Case Studies
1 29
Broader 
Economic
 Benefits
(Mean Rating)
(0=no impact;
1=least impact;
9=most impact)
10
Recommendation: Research funding agencies 
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distributional effects in any discussion or 
assessment of research impact, especially 
when it could influence the allocation of 
research funds
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Academic impact is not correlated 
with wider impacts
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Recommendation: Research funding agencies wishing to 
maximize wider impacts should use broader selection 
criteria than just maximizing knowledge production
Basic biomedical has greater academic 
impact; clinical has greater wider 
impact
Academic Impact Wider Impact
0
1
2
3
4
5
6
7
8
9
Basic
Clinical
Basic
Clinical
Mean Rating
(0=no impact;
1=least impact;
9=most impact)
Recommendation: Funding bodies could prioritise basic 
biomedical or clinical research based on type of 
research they wish to achieve and timescale over 
which they wish to achieve it
We identified a number of factors 
that could explain impact 
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Collaboration is associated with 
high impact 
• Research collaboration is 
associated with high 
academic and wider 
impact
• International 
collaboration is 
associated with high 
academic impact
Motivation and location are associated 
with impact for basic research 
• Basic biomedical research 
with clear clinical 
motivation is associated 
with high academic and 
wider impacts
• Co-location of basic 
biomedical research in a 
clinical setting is associated 
with high wider impact
Strategic thinking is associated with 
impact for clinical research 
• Strategic thinking by 
clinical researchers is 
associated with high 
wider impact
Engaging with those outside the 
academic research system is associated 
with impact
• Engagement with 
practitioners and patients is 
associated with high 
academic and wider 
impacts
• Basic biomedical research 
collaboration with industry 
is associated with high 
academic and wider 
impacts
We identified two factors associated 
with low impact
• Initial rejection of a 
subsequently accepted basic 
biomedical research grant 
may be associated with low 
academic and wider 
impacts
We identified two factors associated 
with low impact
• Initial rejection of a 
subsequently accepted basic 
biomedical research grant 
may be associated with low 
academic and wider 
impacts 
• Negative or null findings 
are associated with low 
academic and wider 
impacts
